Mixed critical reception, with Rotten Tomatoes scores near 38 percent and a Metacritic average of 51, has tempered early tracking for Ridley Scott’s post-apocalyptic drama from an initial $18–23 million range down to roughly $10–14 million. Star power from Jacob Elordi and Josh Brolin, plus the director’s pedigree, supports mid-teens potential, but the R-rated, contemplative tone and late-August slot create downside risk if word-of-mouth proves soft. Tight market spreads between the 9–10 million and 10–11 million brackets reflect ongoing uncertainty around final presales and competition from Coyote vs. Acme, with traders closely watching any last-minute shifts in audience sentiment before the August 28 wide release.